Department of Surgery, University of Auckland, Auckland, New Zealand.
Division of Gastroenterology, Hepatology & Nutrition, University of Pittsburgh Medical Center, Pittsburgh, USA.
Lancet Gastroenterol Hepatol. 2016 Sep;1(1):45-55. doi: 10.1016/S2468-1253(16)30004-8. Epub 2016 Jun 28.
There is a lack of robust estimates of the worldwide incidence and mortality of acute pancreatitis, chronic pancreatitis, pancreatic cysts, and pancreatic cancer in the general population. Our aim was to quantitate and compare the incidence and mortality of major pancreatic diseases in high-quality population-based cohort studies.
Three databases (PubMed, Embase, and Scopus) were searched independently by two reviewers. Data from eligible studies were subject to meta-analysis to obtain global estimates. A number of prespecified subgroup analyses and meta-regression analyses were also done.
48 population-based cohort studies (35 on pancreatic cancer, ten on acute pancreatitis, three on chronic pancreatitis, and none on pancreatic cysts) were identified, with a total study population of 296 million individuals and 119 000 patients with pancreatic diseases. Global estimates of incidence and mortality were 8·14 cases (95% CI 6·63-9·98) per 100 000 person-years and 6·92 deaths (95% CI 3·72-12·89) per 100 000 person-years for pancreatic cancer, 33·74 cases (95% CI 23·33-48·81) per 100 000 person-years and 1·60 deaths (95% CI 0·85-1·58) per 100 000 person-years for acute pancreatitis, and 9·62 cases (95% CI 7·86-11·78) per 100 000 person-years and 0·09 deaths (95% CI 0·02-0·47) per 100 000 person-years for chronic pancreatitis. Subgroup analysis based on the WHO regions showed that the incidences of both pancreatic cancer and acute pancreatitis, and mortality from pancreatic cancer, were significantly higher in the American region than in the European and Western Pacific regions, while the incidence of chronic pancreatitis was significantly higher in the European region than in the American region. Mortality from pancreatic cancer was lowest in the Southeast Asian region. The incidence of chronic pancreatitis was twice as high in men as in women, although there was no difference between sexes for pancreatic cancer or acute pancreatitis.
Globally, acute pancreatitis is the most common pancreatic disease whilst pancreatic cancer is the most lethal. However, their burden is not equal across the globe. The epidemiological estimates reported in this study could inform future high-quality studies.
None.
目前全球范围内普通人群中急性胰腺炎、慢性胰腺炎、胰腺囊肿和胰腺癌的发病率和死亡率缺乏可靠的评估。我们的目的是定量比较高质量人群队列研究中主要胰腺疾病的发病率和死亡率。
两位评审员分别独立在三个数据库(PubMed、Embase 和 Scopus)中进行检索。对符合条件的研究的数据进行荟萃分析,以获得全球估计值。还进行了一些预设的亚组分析和荟萃回归分析。
共确定了 48 项基于人群的队列研究(35 项关于胰腺癌,10 项关于急性胰腺炎,3 项关于慢性胰腺炎,没有关于胰腺囊肿的研究),总研究人群为 2.96 亿人,11.9 万例胰腺疾病患者。全球范围内胰腺癌的发病率和死亡率估计值分别为每 10 万人年 8.14 例(95%CI 6.63-9.98)和每 10 万人年 6.92 例(95%CI 3.72-12.89),急性胰腺炎分别为每 10 万人年 33.74 例(95%CI 23.33-48.81)和每 10 万人年 1.60 例(95%CI 0.85-1.58),慢性胰腺炎分别为每 10 万人年 9.62 例(95%CI 7.86-11.78)和每 10 万人年 0.09 例(95%CI 0.02-0.47)。基于世界卫生组织区域的亚组分析显示,美洲地区胰腺癌和急性胰腺炎的发病率以及胰腺癌的死亡率均显著高于欧洲和西太平洋地区,而欧洲地区慢性胰腺炎的发病率显著高于美洲地区。东南亚地区胰腺癌的死亡率最低。慢性胰腺炎的发病率男性是女性的两倍,而胰腺癌和急性胰腺炎的性别差异无统计学意义。
在全球范围内,急性胰腺炎是最常见的胰腺疾病,而胰腺癌是最致命的。然而,它们在全球的负担并不均等。本研究报告的流行病学估计可以为未来的高质量研究提供信息。
无。